NIDDK Announces the Termination PA-06-176

Notice Number: NOT-DK-07-002

Key Dates
Release Date:   January 23, 2007

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (

The National Institute of Diabetes and Digestive Diseases (NIDDK) announces the termination of the PA-06-176: Insulin Signalling and Receptor Cross-Talk (R21).

New or revised applications will NOT be accepted for the above reference PA after January 23, 2007.

The NIDDK is participating in the NIH Exploratory/Developmental Research Grant Program (Parent R21) which may found at  Information about NIDDK’s R21 program can be found at . Applicants with research interest in areas important to the NIDDK mission, who are considering applying to the Parent R21 announcement, are encouraged to consult with NIDDK Program Staff before submitting an application.


For questions regarding research areas important to the mission of NIDDK please contact:

For Diabetes, Endocrinology, and Metabolic Diseases:

Catherine McKeon, Ph.D.
6707 Democracy Boulevard, Room 6103
Bethesda, MD 20892-5460
Telephone: (301) 594-8810
FAX: (301) 480-3503

For Digestive Diseases, Obesity, and Nutrition:

Robert Karp, Ph.D.
6707 Democracy Boulevard, Room 671
Bethesda, MD 20892-5450
Telephone: (301)451-8875
FAX: (301) 480-8300

For Kidney and Urologic Disorders:

Christian Ketchum, Ph.D.  
6707 Democracy Boulevard, Room 647
Bethesda, MD 20892-5458
Telephone: (301) 594-7717
FAX:  (301) 480-3510

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.